Although some reports have suggested that COX-2 expression is not different among thyroid lesions [146], Ji et al. observed that COX-2 expressions in undifferentiated carcinomas and medullary carcinomas were higher than in PTC and FTC. Here, PTGS2 is linked to thyroid cancer, nonmedullary, 2.